178 related articles for article (PubMed ID: 34362135)
1.
Larribère L; Utikal J
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362135
[TBL] [Abstract][Full Text] [Related]
2. NF1-RAC1 axis regulates migration of the melanocytic lineage.
Larribère L; Cakrapradipta Wibowo Y; Patil N; Abba M; Tundidor I; Aguiñón Olivares RG; Allgayer H; Utikal J
Transl Oncol; 2020 Dec; 13(12):100858. PubMed ID: 32891903
[TBL] [Abstract][Full Text] [Related]
3. Multiple roles of NF1 in the melanocyte lineage.
Larribère L; Utikal J
Pigment Cell Melanoma Res; 2016 Jul; 29(4):417-25. PubMed ID: 27155159
[TBL] [Abstract][Full Text] [Related]
4. Targeted Therapy-Resistant Melanoma Cells Acquire Transcriptomic Similarities with Human Melanoblasts.
Larribère L; Kuphal S; Sachpekidis C; ; Hüser L; Bosserhoff A; Utikal J
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30453548
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene.
Boucneau J; De Schepper S; Vuylsteke M; Van Hummelen P; Naeyaert JM; Lambert J
Pigment Cell Res; 2005 Aug; 18(4):285-99. PubMed ID: 16033338
[TBL] [Abstract][Full Text] [Related]
6. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.
Mahalingam M
Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538
[TBL] [Abstract][Full Text] [Related]
7. Learning from Embryogenesis-A Comparative Expression Analysis in Melanoblast Differentiation and Tumorigenesis Reveals miRNAs Driving Melanoma Development.
Linck-Paulus L; Lämmerhirt L; Völler D; Meyer K; Engelmann JC; Spang R; Eichner N; Meister G; Kuphal S; Bosserhoff AK
J Clin Med; 2021 May; 10(11):. PubMed ID: 34073664
[TBL] [Abstract][Full Text] [Related]
8. NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model.
Larribere L; Wu H; Novak D; Galach M; Bernhardt M; Orouji E; Weina K; Knappe N; Sachpekidis C; Umansky L; Beckhove P; Umansky V; De Schepper S; Kaufmann D; Ballotti R; Bertolotto C; Utikal J
Pigment Cell Melanoma Res; 2015 Jul; 28(4):407-16. PubMed ID: 25824590
[TBL] [Abstract][Full Text] [Related]
9. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
10. CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
Oncotarget; 2018 Jul; 9(58):31264-31277. PubMed ID: 30131853
[TBL] [Abstract][Full Text] [Related]
11. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
[TBL] [Abstract][Full Text] [Related]
12. Status of the NF1 tumor suppressor locus in uveal melanoma.
Foster WJ; Fuller CE; Perry A; Harbour JW
Arch Ophthalmol; 2003 Sep; 121(9):1311-5. PubMed ID: 12963615
[TBL] [Abstract][Full Text] [Related]
13. A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.
Way GP; Allaway RJ; Bouley SJ; Fadul CE; Sanchez Y; Greene CS
BMC Genomics; 2017 Feb; 18(1):127. PubMed ID: 28166733
[TBL] [Abstract][Full Text] [Related]
14. miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma.
Stark MS; Bonazzi VF; Boyle GM; Palmer JM; Symmons J; Lanagan CM; Schmidt CW; Herington AC; Ballotti R; Pollock PM; Hayward NK
Oncotarget; 2015 Jul; 6(19):17753-63. PubMed ID: 25980496
[TBL] [Abstract][Full Text] [Related]
15. NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.
Cirenajwis H; Lauss M; Ekedahl H; Törngren T; Kvist A; Saal LH; Olsson H; Staaf J; Carneiro A; Ingvar C; Harbst K; Hayward NK; Jönsson G
Mol Oncol; 2017 Apr; 11(4):438-451. PubMed ID: 28267273
[TBL] [Abstract][Full Text] [Related]
16. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1.
Ishii S; Han S; Shiiba K; Mizoi T; Okabe M; Horii A; Nagura H; Matsuno S; Sasaki I
Int J Clin Oncol; 2001 Aug; 6(4):201-4. PubMed ID: 11706558
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.
Gómez L; Rubio MP; Martin MT; Vázquez JJ; Idoate M; Pastorfide G; Pestaña A; Seizinger BR; Barnhill RL; Castresana JS
J Invest Dermatol; 1996 Mar; 106(3):432-6. PubMed ID: 8648172
[TBL] [Abstract][Full Text] [Related]
19.
Hayashi T; Desmeules P; Smith RS; Drilon A; Somwar R; Ladanyi M
Clin Cancer Res; 2018 Mar; 24(6):1436-1447. PubMed ID: 29127119
[No Abstract] [Full Text] [Related]
20. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.
Gutzmer R; Herbst RA; Mommert S; Kiehl P; Matiaske F; Rütten A; Kapp A; Weiss J
Hum Genet; 2000 Oct; 107(4):357-61. PubMed ID: 11129335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
